Primary among them is a proposal to offer third parties licenses to PacBio and Illumina long-read patents. However, by setting a hearing date for August, the FTC has further complicated Illumina’s plans.Illumina’s agreement to buy PacBio, already extended once, expires March 31. /business/instrumentation/FTC-seeks-block-Illuminas-deal/98/i1 20200103 Agency labels Illumina a ‘monopolist’ and sets a hearing on the next-generation sequencing acquisition for August Concentrates 98 1 /magazine/98/09801.html FTC seeks to block Illumina’s deal for PacBio Instrumentation, sequencing, DNA, Pacific Biosciences, Illumina con bus Marc S.
by Marc S. Reisch |
January 03, 2020